Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis

Lorenzo J Cervantes, Francis S MahDepartment of Ophthalmology, Cornea and External Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USAAbstract: Bacterial conjunctivitis is a common infectious disease of the eye, characterized by conjunctival hyperemia, eyelid edema, and p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cervantes LJ, Mah FS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/4a065ecae35f4ce190c02a2c3d4007c7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4a065ecae35f4ce190c02a2c3d4007c7
record_format	dspace
spelling	oai:doaj.org-article:4a065ecae35f4ce190c02a2c3d4007c72021-12-02T01:36:56ZClinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis1177-54671177-5483https://doaj.org/article/4a065ecae35f4ce190c02a2c3d4007c72011-04-01T00:00:00Zhttp://www.dovepress.com/clinical-use-of-gatifloxacin-ophthalmic-solution-for-treatment-of-bact-a7119https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Lorenzo J Cervantes, Francis S MahDepartment of Ophthalmology, Cornea and External Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USAAbstract: Bacterial conjunctivitis is a common infectious disease of the eye, characterized by conjunctival hyperemia, eyelid edema, and purulent discharge. Although the prevalence and incidence are not well reported, bacterial conjunctivitis represents one of the most frequent causes of patient visits to both primary care physicians and ophthalmologists. Most cases of nongonococcal and nonchlamydial bacterial conjunctivitis are self-limiting and may resolve without intervention. There is a place for treatment, however, which allows for a shorter time to clinical and microbiological resolution which may decrease the mild morbidity, decrease health care costs of visits and potential complications, return patients back to school or the work force, and limit the potential spread of this communicable infection. Gatifloxacin ophthalmic solution is a broad spectrum 8-methoxyfluroroquinolone bactericidal antibiotic, with good activity against Staphylococcus aureus, Streptococcus species, and Gram-negative pathogens. It also has a relatively good resistance profile, making it a more than adequate choice in the treatment of bacterial conjunctivitis when therapy is warranted.Keywords: gatifloxacin, Zymar&reg;, Zymaxid&reg;, bacterial conjunctivitis Cervantes LJMah FSDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 495-502 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Cervantes LJ Mah FS Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
description	Lorenzo J Cervantes, Francis S MahDepartment of Ophthalmology, Cornea and External Disease, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USAAbstract: Bacterial conjunctivitis is a common infectious disease of the eye, characterized by conjunctival hyperemia, eyelid edema, and purulent discharge. Although the prevalence and incidence are not well reported, bacterial conjunctivitis represents one of the most frequent causes of patient visits to both primary care physicians and ophthalmologists. Most cases of nongonococcal and nonchlamydial bacterial conjunctivitis are self-limiting and may resolve without intervention. There is a place for treatment, however, which allows for a shorter time to clinical and microbiological resolution which may decrease the mild morbidity, decrease health care costs of visits and potential complications, return patients back to school or the work force, and limit the potential spread of this communicable infection. Gatifloxacin ophthalmic solution is a broad spectrum 8-methoxyfluroroquinolone bactericidal antibiotic, with good activity against Staphylococcus aureus, Streptococcus species, and Gram-negative pathogens. It also has a relatively good resistance profile, making it a more than adequate choice in the treatment of bacterial conjunctivitis when therapy is warranted.Keywords: gatifloxacin, Zymar&reg;, Zymaxid&reg;, bacterial conjunctivitis
format	article
author	Cervantes LJ Mah FS
author_facet	Cervantes LJ Mah FS
author_sort	Cervantes LJ
title	Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
title_short	Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
title_full	Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
title_fullStr	Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
title_full_unstemmed	Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
title_sort	clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/4a065ecae35f4ce190c02a2c3d4007c7
work_keys_str_mv	AT cervanteslj clinicaluseofgatifloxacinophthalmicsolutionfortreatmentofbacterialconjunctivitis AT mahfs clinicaluseofgatifloxacinophthalmicsolutionfortreatmentofbacterialconjunctivitis
_version_	1718402955216945152

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis

Ejemplares similares